medline inc - MDLN

MDLN

Close Chg Chg %
43.30 1.63 3.76%

Open Market

44.93

+1.63 (3.76%)

Volume: 1.26M

Last Updated:

Jan 22, 2026, 1:15 PM EDT

Company Overview: medline inc - MDLN

MDLN Key Data

Open

$43.59

Day Range

43.41 - 45.41

52 Week Range

N/A - N/A

Market Cap

$35.13B

Shares Outstanding

811.42M

Public Float

418.29M

Beta

N/A

Rev. Per Employee

N/A

P/E Ratio

27.35

EPS

$1.58

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

6.09M

 

MDLN Performance

1 Week
 
0.07%
 
1 Month
 
6.00%
 
3 Months
 
N/A
 
1 Year
 
N/A
 
5 Years
 
N/A
 

MDLN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 26
Full Ratings ➔

About medline inc - MDLN

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

MDLN At a Glance

Medline, Inc.
3 Lakes Drive
Northfield, Illinois 60093
Phone 1-847-949-5500 Revenue 25.51B
Industry Medical Specialties Net Income 1.20B
Sector Health Technology 2024 Sales Growth 9.797%
Fiscal Year-end 12 / 2025 Employees 43,000
View SEC Filings

MDLN Valuation

P/E Current 27.892
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

MDLN Efficiency

Revenue/Employee 593,186.047
Income Per Employee 27,906.977
Receivables Turnover 7.924
Total Asset Turnover 0.708

MDLN Liquidity

Current Ratio 3.39
Quick Ratio 1.564
Cash Ratio 0.102

MDLN Profitability

Gross Margin 24.664
Operating Margin 8.723
Pretax Margin 4.885
Net Margin 4.705
Return on Assets 3.329
Return on Equity 7.164
Return on Total Capital 3.59
Return on Invested Capital 3.585

MDLN Capital Structure

Total Debt to Total Equity 102.269
Total Debt to Total Capital 50.561
Total Debt to Total Assets 46.97
Long-Term Debt to Equity 103.633
Long-Term Debt to Total Capital 50.10
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Medline Inc - MDLN

Collapse All in section
All values USD millions. 2022 2023 2024 5-year trend
Sales/Revenue
- 21.45B 23.23B 25.51B
Sales Growth
- - +8.31% +9.80%
-
Cost of Goods Sold (COGS) incl D&A
- 16.89B 18.01B 19.22B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- 933.00M 951.00M 977.00M
Depreciation
- 273.00M 289.00M 292.00M
Amortization of Intangibles
- 660.00M 662.00M 685.00M
COGS Growth
- - +6.61% +6.71%
-
Gross Income
- 4.56B 5.22B 6.29B
Gross Income Growth
- - +14.61% +20.45%
-
Gross Profit Margin
- +21.25% +22.48% +24.66%
2022 2023 2024 5-year trend
SG&A Expense
- 3.68B 3.87B 4.11B
Research & Development
- 58.00M 60.00M 67.00M
Other SG&A
- 3.62B 3.81B 4.04B
SGA Growth
- - +5.20% +6.23%
-
Other Operating Expense
- 11.00M (88.00M) (42.00M)
Unusual Expense
- (9.00M) 161.00M 83.00M
EBIT after Unusual Expense
- 879.00M 1.28B 2.14B
Non Operating Income/Expense
- 42.00M 356.00M 413.00M
Non-Operating Interest Income
- 27.00M 237.00M 280.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 911.00M 1.38B 1.31B
Interest Expense Growth
- - +50.93% -4.80%
-
Gross Interest Expense
- 911.00M 1.38B 1.31B
Interest Capitalized
- - - -
-
Pretax Income
- 10.00M 264.00M 1.25B
Pretax Income Growth
- - +2,540.00% +371.97%
-
Pretax Margin
- +0.05% +1.14% +4.88%
Income Tax
- 35.00M 30.00M 46.00M
Income Tax - Current - Domestic
- 25.00M 7.00M 12.00M
Income Tax - Current - Foreign
- 24.00M 46.00M 58.00M
Income Tax - Deferred - Domestic
- - - 2.00M
-
Income Tax - Deferred - Foreign
- (16.00M) (23.00M) (24.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
- (25.00M) 234.00M 1.20B
Minority Interest Expense
- - - -
-
Net Income
- (25.00M) 234.00M 1.20B
Net Income Growth
- - +1,036.00% +412.82%
-
Net Margin Growth
- -0.12% +1.01% +4.70%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
- (25.00M) 234.00M 1.20B
Preferred Dividends
- - - -
-
Net Income Available to Common
- (25.00M) 234.00M 1.20B
EPS (Basic)
- -0.0313 0.2926 1.5004
EPS (Basic) Growth
- - +1,034.82% +412.78%
-
Basic Shares Outstanding
- 799.80M 799.80M 799.80M
EPS (Diluted)
- -0.0313 0.2926 1.5004
EPS (Diluted) Growth
- - +1,034.82% +412.78%
-
Diluted Shares Outstanding
- 799.80M 799.80M 799.80M
EBITDA
- 1.80B 2.40B 3.20B
EBITDA Growth
- - +32.83% +33.70%
-
EBITDA Margin
- +8.41% +10.31% +12.55%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 47.08
Number of Ratings 26 Current Quarters Estimate 0.29
FY Report Date 03 / 2026 Current Year's Estimate 1.464
Last Quarter’s Earnings 0.24 Median PE on CY Estimate N/A
Year Ago Earnings 1.20 Next Fiscal Year Estimate 1.611
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 21 21 23 23
Mean Estimate 0.29 0.33 1.46 1.61
High Estimates 0.31 0.35 1.52 1.73
Low Estimate 0.24 0.27 1.22 1.31
Coefficient of Variance 4.84 4.31 4.18 6.51

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 18
OVERWEIGHT 3
HOLD 5
UNDERWEIGHT 0
SELL 0
MEAN Overweight

Medline Inc in the News